Questions with the most recent answer or edit.
Numbers first: a GLP-1 receptor agonist · 5 mg. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the…
Setup, so nobody has to ask: 97.1% · batch certificate. I have read the primary source rather than the summary, which has left me with more questions. I understand…
The case in front of me: 40 mg · 2 mL. Please show the division. I want to check my own against yours. I would like the general form as well as the specific number,…
Setup, so nobody has to ask: 60 mg · cagrilintide. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so…
Conditions: survodutide · 20 mg/mL · ten weeks. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at…
The case in front of me: ecnoglutide · sterile water for injection. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have…
What I am working with: VendorInvestigate · ecnoglutide. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than…
What I am working with: aggregation · mazdutide · minus 20 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…
For reference: HJ · QYB · Singapore. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can stop…
The particulars: STEP 5 · nausea. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable with…
The case in front of me: 99.1% · liraglutide · FGP. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…
Conditions: nausea · four · retatrutide. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of every batch,…
Stated plainly: ERP · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
For reference: SURMOUNT-3 · tirzepatide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
What I have: injection-site erythema · oral semaglutide · PIONEER-4. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not…
The specifics, since they change the answer: 15 mg · 5 mL · phosphate-buffered diluent · dulaglutide. I would like to define my thresholds before I have a result, for…
Timing, since it always gets asked: this started nine days after a dose step. I want to understand what this actually establishes, as opposed to what it is being used…
The particulars: oral semaglutide · ten weeks · 25 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I…
For reference: Hangzhou · the Netherlands. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
Stated plainly: dimerisation · cagrilintide · 25 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would…
What I have: 99.4% · Janoshik · 97.1% · PeptideMeter. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
For reference: 1.7 mg · three weeks · injection-site erythema. I would like the mechanism, because I want to be able to reason about the cases nobody has written…
The specifics, since they change the answer: Medutest · GL Biochem (Shanghai). I would like help reading this properly rather than being told what conclusion to…
Setup, so nobody has to ask: ecnoglutide · mazdutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…